153 related articles for article (PubMed ID: 26118903)
1. Quantifying epitope presentation using mass spectrometry.
Croft NP; Purcell AW; Tscharke DC
Mol Immunol; 2015 Dec; 68(2 Pt A):77-80. PubMed ID: 26118903
[TBL] [Abstract][Full Text] [Related]
2. Efficiency and mechanism of antigen-specific CD8+ T-cell activation using synthetic long peptides.
Zandvliet ML; Kester MG; van Liempt E; de Ru AH; van Veelen PA; Griffioen M; Guchelaar HJ; Falkenburg JH; Meij P
J Immunother; 2012; 35(2):142-53. PubMed ID: 22306902
[TBL] [Abstract][Full Text] [Related]
3. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
[TBL] [Abstract][Full Text] [Related]
4. Processing of exogenous hepatitis B surface antigen particles for Ld-restricted epitope presentation depends on exogenous beta2-microglobulin.
Schirmbeck R; Thoma S; Reimann J
Eur J Immunol; 1997 Dec; 27(12):3471-84. PubMed ID: 9464837
[TBL] [Abstract][Full Text] [Related]
5. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
6. An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies.
Nielsen JS; Wick DA; Tran E; Nelson BH; Webb JR
J Immunol Methods; 2010 Aug; 360(1-2):149-56. PubMed ID: 20637775
[TBL] [Abstract][Full Text] [Related]
7. The role of mRNA translation in direct MHC class I antigen presentation.
Apcher S; Manoury B; Fåhraeus R
Curr Opin Immunol; 2012 Feb; 24(1):71-6. PubMed ID: 22341517
[TBL] [Abstract][Full Text] [Related]
8. Impact of epitope density on CD8
Cosma GL; Eisenlohr LC
Mol Immunol; 2019 Sep; 113():120-125. PubMed ID: 30948189
[TBL] [Abstract][Full Text] [Related]
9. Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring.
Tan CT; Croft NP; Dudek NL; Williamson NA; Purcell AW
Proteomics; 2011 Jun; 11(11):2336-40. PubMed ID: 21598389
[TBL] [Abstract][Full Text] [Related]
10. Impact of CD8-MHC class I interaction in detection and sorting efficiencies of antigen-specific T cells using MHC class I/peptide multimers: contribution of pMHC valency.
Neveu B; Echasserieau K; Hill T; Kuus-Reichel K; Houssaint E; Bonneville M; Saulquin X
Int Immunol; 2006 Jul; 18(7):1139-45. PubMed ID: 16751231
[TBL] [Abstract][Full Text] [Related]
11. Molecular challenges imposed by MHC-I restricted long epitopes on T cell immunity.
Josephs TM; Grant EJ; Gras S
Biol Chem; 2017 Aug; 398(9):1027-1036. PubMed ID: 28141543
[TBL] [Abstract][Full Text] [Related]
12. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
13. In silico analysis of MHC-I restricted epitopes of Chikungunya virus proteins: Implication in understanding anti-CHIKV CD8(+) T cell response and advancement of epitope based immunotherapy for CHIKV infection.
Pratheek BM; Suryawanshi AR; Chattopadhyay S; Chattopadhyay S
Infect Genet Evol; 2015 Apr; 31():118-26. PubMed ID: 25643869
[TBL] [Abstract][Full Text] [Related]
14. Antigen presentation: structural themes and functional variations.
Braciale TJ; Braciale VL
Immunol Today; 1991 Apr; 12(4):124-9. PubMed ID: 1711855
[TBL] [Abstract][Full Text] [Related]
15. T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.
Rojas JM; Rodríguez-Calvo T; Peña L; Sevilla N
Vaccine; 2011 Sep; 29(40):6848-57. PubMed ID: 21807057
[TBL] [Abstract][Full Text] [Related]
16. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
17. Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity.
Harndahl M; Rasmussen M; Roder G; Dalgaard Pedersen I; Sørensen M; Nielsen M; Buus S
Eur J Immunol; 2012 Jun; 42(6):1405-16. PubMed ID: 22678897
[TBL] [Abstract][Full Text] [Related]
18. Carfilzomib alters the HLA-presented peptidome of myeloma cells and impairs presentation of peptides with aromatic C-termini.
Kowalewski DJ; Walz S; Backert L; Schuster H; Kohlbacher O; Weisel K; Rittig SM; Kanz L; Salih HR; Rammensee HG; Stevanović S; Stickel JS
Blood Cancer J; 2016 Apr; 6(4):e411. PubMed ID: 27058226
[TBL] [Abstract][Full Text] [Related]
19. Biochemical analysis of naturally processed antigenic peptides presented by MHC class I molecules.
Kanaseki T; Shastri N
Methods Mol Biol; 2013; 960():179-185. PubMed ID: 23329488
[TBL] [Abstract][Full Text] [Related]
20. Perpetual complexity: predicting human CD8
Di Carluccio AR; Triffon CF; Chen W
Immunol Cell Biol; 2018 Apr; 96(4):358-369. PubMed ID: 29424002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
